From: Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy
 | Evidence of no or negative impact (leave out of programs) | Uncertain evidence (need for additional research before including in programs) | Some evidence (may include in programs, but further evaluation is warranted) | Clear evidence (merits inclusion in programs) |
---|---|---|---|---|
Calcium supplementation for pregnancy-induced hypertension | Â | X1 | Â | Â |
Anti-hypertensives | Â | X | Â | Â |
Anti-platelet agents | Â | X | Â | Â |
Anti-oxidants | X | Â | Â | Â |
Heparin | Â | Â | Â | X (for certain conditions) |
Management of intrahepatic cholestasis | Â | Â | X | Â |
Plasma exchange | Â | X | Â | Â |
Cervical cerclage | Â | X | Â | Â |
Anti-helminthics | Â | Â | X | Â |
Syphilis screening and treatment | Â | Â | X | Â |
Antibiotics for BV, asymptomatic bacteriuria, and GBS | Â | X | Â | Â |
Antibiotics for PROM/PPROM | Â | X | Â | Â |
Anti-malarials | Â | Â | X2 | Â |
ITNs | Â | Â | Â | X |
PMTCT for HIV | X2 | Â | Â | Â |
Periodontal care | Â | X | Â | Â |